ClinicalTrials.Veeva

Menu

Outcome of Patients Treated With ECLS

N

Nanjing Medical University

Status

Enrolling

Conditions

Acute Respiratory Distress Syndrome
Heart Failure
Acute Respiratory Failure
Cardiogenic Shock
Cardiac Arrest

Treatments

Device: ECMO

Study type

Observational

Funder types

Other

Identifiers

NCT04405817
ECLS-Jsph

Details and patient eligibility

About

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Enrollment

300 estimated patients

Sex

All

Ages

1 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients receiving ECMO for circulatory and/or respiratory support

Exclusion criteria

  • Refusal of consent

Trial contacts and locations

1

Loading...

Central trial contact

Yong-feng Shao, MD; Hong Liu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems